UNIVERSITY OF KANSAS SCHOOL OF MEDICINE Academic Curriculum Vitae Please consult the and with any questions. Or mail . Date March 2017 Applicant Information: Full Name Sufi M. Thomas Degree(s) PhD Current Academic Rank Associate Professor Primary Department Otolaryngology and Cancer Biology Secondary Department Cancer Biology, and Anatomy and Cell Biology Office Address 4031 Wahl Hall East Office Phone 913-588-6664 Mailstop 3040 Professional Development: Undergraduate and Graduate Education: Years (inclusive) Degree Institution 1992 BS (Life Sciences) Bombay University, India 1994 MS (Life Sciences – Biotechnology) Mumbai University, India Postgraduate Education: Years (inclusive) Degree Institution 2000 PhD (Applied Biology) Mumbai University, India Continuing Education: by applicant, such as any CME, Interprofessional Development, Doctors as Educators, Leadership Development, etc. Year(s) Course Title Description 2016 Doctors as Educators Phase II, learnt new teaching techniques including flipped classrooms and small groups Academic and Professional Appointments and Activities: Month and Year Position Institution 1993 Research training in Molecular Biology, Cytogenetics Laboratory Banaras Hindu University, UP, India 1994-2000 PhD, Genetic Engineering Unit, Cancer Research Institute Mumbai University, Mumbai, India 2000-2004 Research Associate, Department of Otolaryngology University of Pittsburgh Medical Center 2004-2013 Research Assistant Professor, Department of Otolaryngology University of Pittsburgh Medical Center 2012-2013 Secondary Appointment in the Department of Pharmacology and Chemical Biology University of Pittsburgh
2009 Department of Otolaryngology Head and Neck SPORE meeting Head and Neck Cancer Preclinical Models Formal Presentation 1 n/a 2010 Eye and Ear Foundation Scientific Advisory Meeting Targeting the epidermal growth factor receptor with antisense guanidinium, peptide nucleic acids Formal Presentation 1 n/a 2011 Fourth International Symposium on Translational Cancer Research: Recent developments in cancer prevention Cross-talk between head and neck cancer cells and stromal fibroblasts facilitates tumor progression Formal Presentation 1 n/a 2012 University of Texas EGFR antisense gene therapy: Progress toward systemic delivery Formal Presentation 1 n/a 2012 Department of Pharmacology and Chemical Biology Seminar Series, University of Pittsburgh EGFR antisense gene therapy: Progress toward systemic delivery Formal Presentation 1 n/a 2012 Department of Otolaryngology, University of Kansas Medical Center Deviant of head and neck cancer progression Formal Presentation 1 n/a 2013 Department of Otolaryngology, University of Rochester Medical Center Deviant of head and neck cancer progression Formal Presentation 1 n/a 2013 Department of Otolaryngology, University of Kansas Medical Center Demystifying Translational Research Grand Rounds 1 hour n/a 2013 Department of Pharmacology, Toxicology, University of Kansas Medical Center Antisense Gene Therapy Using Guanidinium Peptide Nucleic Acid Oligomers Formal Presentation 1 hour n/a 2013 Cancer Biology Monthly Meeting, University of Kansas The role of fibroblasts in head and neck cancer progression Formal Presentation 1 hour n/a associated
2014 University of Kansas Cancer Center, Cancer Biology Program Meeting of head and Neck Cancer Formal Presentation 15 min ~70 Faculty 2014 University of Kansas Cancer Center, Cancer Biology Program Meeting Head and neck Cancer: A True Team Player Formal Presentation 1 hour ~30 KUMC faculty 2014 Head and Neck Cancer Interest Head and Neck Cancer Research: An Overview Formal Presentation 30 min ~30 KUMC faculty, residents and students 2014 Department of Otolaryngology, Resident Conference Research Design and Writing Manuscripts Formal Presentation 30 min ~25 Residents and faculty 2014 KUMC Head and Neck Cancer Support Group Head and Neck Cancer Research: Finding the right hammer to crack a tough nut Formal Presentation 1 h ~40 Head and Neck Cancer Survivors 2014 2014 Kansas IDeA Network of Biomedical Research Excellence (K-INBRE) Symposium Fibroblasts: The New Target for Cancer Treatment Formal Presentation 20 min <500 Faculty and undergraduate students 2014 Department of Anatomy and Cell Biology, University of Kansas Medical Center Fibroblasts: The New Target for Cancer Treatment Formal Presentation 1 hour ~50 Faculty and students 2014 University of Kansas Cancer Center, Clinical Research and Translational Meeting Promising Molecular Targeted Therapies for Head and Neck Cancer Formal Presentation 1 hour ~50 Faculty 2014 Doctors as Educators Angiogenesis Lecture 10 min 15 Faculty 2014 Carcinogenesis & Cancer Biology (PHCL 701) Mechanisms of Angiogenesis Lecture 2 ½ hours 8 Graduate students 2014 Molecular Mechanisms of Neurological Diseases (NURO 848) Brain Tumors Lecture Paper Discussion 2 ½ hours 2 ½ hours 3 Graduate students 2014 Mechanisms of tumor development and progression (CBIO-800) The Role of Tumor Associated Stroma in Head Lecture Discussion 2 ½ hours 2 ½ hours 4 Graduate students heterogeneity associated
and Neck Cancer Progression 2015 Carcinogenesis & Cancer Biology (PHCL 701) Mechanisms of Angiogenesis Lecture 2 ½ hours 17 Graduate students 2016 Molecular Mechanisms of Neurological Diseases (NURO 848) Brain Tumors Lecture Paper Discussion 2 ½ hours 2 ½ 8 Graduate students 2016 Mechanisms of tumor development and progression (CBIO-800) The Role of Associated Stroma in Head and Neck Cancer Progression Lecture Paper Discussion 2 ½ hours 2 ½ hours 10 Graduate students 2016 Cellular and Molecular Mechanisms of Signal Transduction in Cancer (CBY 820) Ras-Gap Signaling Lecture Paper Discussion 45 min 1 h 4 Graduate students 2016 Carcinogenesis & Cancer Biology (PHCL 701) Mechanisms of Angiogenesis Lecture 2 ½ hours 4 Graduate students 2017 Cellular and Molecular Mechanisms of Signal Transduction in Cancer (CBY 820) Ras-Gap Signaling Lecture Paper Discussion 45 min 1 h 8 Graduate students Non-didactic: (i.e. workshops, labs, seminars, discussion groups, or journal clubs) Academic Year Title and Course Number Presentation Title Instruction Learner Type Hours (actual instruction) Number of Learners Type of Learner(s) (i.e. medical & grad students, residents) 2014 Practice Based Learning group 12 hours 9 Medical Students, Year 2 2015 Practice Based Learning Small group 12 hours 9 Medical Students, Year 1 2016-2017 Practice Learning Small group 12 9 Medical Students, Year 2 2016 CBCL Small group 14 hours 9 Medical Students, Year 1
Principal Investigator Investigators of Grant/Contract/Trial Funding Source Direct Costs/ Funding Inclusive Years of Award Status Dr. Sufi Thomas Start-up funds Department of Otolaryngology 2013-2016 In Progress Dr. Sufi Thomas Intratumor-heterogeneity of head and neck cancer University of Kansas Cancer Center, Cancer Biology Program Award $6000 2014-2015 Completed Dr. Sufi Thomas Optimization of GZ17 as a novel therapeutic agent for head and neck cancer Likarda, LLC Sponsored Research Agreement $80,000 2014-2016 Completed Dr. Sufi Thomas In silico analysis of and in vivo antitumor efficacy in head and neck cancer preclinical models Likarda, LLC Sponsored Research Agreement $100,000 2015-2016 In Progress Dr. Sufi Thomas Targeting mutant EGFR in glioma University of Kansas Cancer Center $35000 2015-2016 Completed Dr. Sufi Thomas Drs. Shnayder and Dai Role of tumor-associated fibroblasts in head and neck cancer metabolism American Head and Neck Society $10,000 2016-2017 Awarded Submitted Grants, Contracts, and Clinical Trials (include all grants, contracts, and clinical trials submitted, even if unfunded) Principal Investigator Investigators of Grant/Contract/Trial Funding Source Direct Costs/ Funding Inclusive Years of Award Status Dr. Sufi Thomas Dr. Danith Ly Mutation-specific guanidinium peptide nucleic acid for cancer therapy National Cancer Institute $1,365,450 2016-2021 Scored Dr. Sufi Thomas Assessing the role of TAFs in Anal Carcinoma O’Sullivan Foundation $30,000 2017-2018 Funded Dr. Sufi Thomas Dr. Shrikant Anant Targeting Stemness in Head and Neck Squamous Cell Carcinoma NCI, RO1 $1,247,286 2016-2022 Scored Dr. Sufi Thomas Testing natural compounds in HNSCC Genzada Inc $300,000 2016-no end Under Review Dr. Sufi Thomas fibroblasts in head and neck cancer metabolism and progression COBRE Pilot Project $ 449,999 2017-2020 Pending notification Dr. Sufi Thomas Tumor-associated fibroblasts in head and neck cancer metabolism and progression Leid Pilot Grand $ 25,000 2017-2018 Not funded Dr. Tomoo Iwakuma Dr. Sufi Thomas Control of mutant p53 stability via the mevalonate axis NIH/NCI R01CA214916 $1,247,286 2017-2022 Pending award notification Scholarly Publications: